Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cassian Yee

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responsesC Siddiq Abdul-Alim, Yongqing Li, Cassian Yee
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
An Update on Adoptive T-Cell Therapy and Neoantigen VaccinesPatrick A Ott, Gianpietro Dotti, Cassian Yee, et al.
JCI Insight|May 24, 2021
Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation programFarah Hasan, Yulun Chiu, Rebecca M Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent mannerSelin Oncul, Hani Lee, Shailbala Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingAnna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
The Journal of Investigative Dermatology|June 20, 2008
CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumorsKavita V Shah, Andy J Chien, Cassian Yee, et al.
Journal for Immunotherapy of Cancer|January 25, 2025
Urine proteomics defines an immune checkpoint-associated nephritis signatureJames P Long, Shailbala Singh, Yanlan Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapyJeffrey Weber, Michael Atkins, Patrick Hwu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Autoreactive T cells in healthy individualsNancy A Danke, David M Koelle, Cassian Yee, et al.
Journal for Immunotherapy of Cancer|April 30, 2026
First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case studyCasey Bermack, Shailbala Singh, Guangsheng Pei, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responsesC Siddiq Abdul-Alim, Yongqing Li, Cassian Yee
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 18, 2019
An Update on Adoptive T-Cell Therapy and Neoantigen VaccinesPatrick A Ott, Gianpietro Dotti, Cassian Yee, et al.
JCI Insight|May 24, 2021
Hypoxia acts as an environmental cue for the human tissue-resident memory T cell differentiation programFarah Hasan, Yulun Chiu, Rebecca M Shaw, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 18, 2026
B cell depletion promotes melanoma tumor growth in a CD4+ T cell-dependent mannerSelin Oncul, Hani Lee, Shailbala Singh, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 14, 2023
Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modelingAnna M Mc Laughlin, Peter A Milligan, Cassian Yee, et al.
The Journal of Investigative Dermatology|June 20, 2008
CTLA-4 is a direct target of Wnt/beta-catenin signaling and is expressed in human melanoma tumorsKavita V Shah, Andy J Chien, Cassian Yee, et al.
Journal for Immunotherapy of Cancer|January 25, 2025
Urine proteomics defines an immune checkpoint-associated nephritis signatureJames P Long, Shailbala Singh, Yanlan Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2011
White paper on adoptive cell therapy for cancer with tumor-infiltrating lymphocytes: a report of the CTEP subcommittee on adoptive cell therapyJeffrey Weber, Michael Atkins, Patrick Hwu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 7, 2004
Autoreactive T cells in healthy individualsNancy A Danke, David M Koelle, Cassian Yee, et al.
Journal for Immunotherapy of Cancer|April 30, 2026
First-in-human use of recombinant IL-7 to potentiate antigen-specific T cell therapy: a single patient case studyCasey Bermack, Shailbala Singh, Guangsheng Pei, et al.
Pageof 15